the aid library

LIST OPTIONS

Filter

14665

Best practice guidance: How to respond to vocal vaccine deniers in public

World Health Organization (WHO) (2016) C_WHO

This guidance document provides basic broad principles for a spokesperson of any health authority on how to respond to vocal vaccine deniers. The suggestions are based on psychological research on persuasion, on research in public health, communication studies and on WHO risk communication guide... more

The Defeat-NCD Partnership

The Defeat-NCD Partnership (2024) CC2

The Defeat-NCD Partnership prioritises poorer countries because they bear the brunt of the enormous impact of NCDs with some 48% of premature deaths occurring in low and lower-middle income countries. The resident of a low-income country faces a lifetime chance of 20-30% of dying from an NCD under t... more

Download (628)

View PDF (669)

A primary health care approach to obesity prevention and management in children and adolescents: policy brief

World Health Organisation (WHO) (2023) C_WHO

Obesity in all age groups, including children and adolescents, is a public health challenge across all settings. Obesity is now classified as a complex multifactorial chronic disease and not just a risk factor for other noncommunicable diseases and comorbidities. Recognizing the significance of prim... more

Download (1120)

View PDF (2103)

West and Central Africa: Humanitarian Bulletin, March 2015

UN Office for the Coordination of Humanitarian Affairs (2015)

USD$ 28 million allocated from UN Central Emergency Fund to assist people affected by Boko Haram’s insurgency. Boko Haram, insecurity exert misery in Cameroon’s Far North Region. Millions of people in Ebola-affected countries risk serious food shortages during the June-August lean ... more

Download (265)

View PDF (366)

Surveillance of NCDs - arabic version

World Health Organization WHO; Eastern Mediterranean Region World Health Organization (WHO) (2024) C_WHO

The WHO Eastern Mediterranean Region's Noncommunicable Diseases (NCD) Data and Statistics page offers comprehensive information on NCD surveillance, including mortality rates, morbidity, and risk factor exposures. It emphasizes the importance of monitoring NCD trends to inform prevention and control... more

Download (305)

View PDF (312)

Coping With Stress During Infectious Disease Outbreaks

Substance Abuse and Mental Health Services Administration SAMHSA (2020) C1

When you hear, read, or watch news about an outbreak of an infectious disease such as Ebola, you may feel anxious and show signs of stress—even when the outbreak affects people far from where you live and you are at low or no risk of getting sick. These signs of stress are normal, and may be more ... more

Download (287)

View PDF (197)

Surveillance of NCDs

World Health Organization WHO; Eastern Mediterranean Region World Health Organization (WHO) (2024) C_WHO

Download (1233)

View PDF (2042)

Missed: Polio Communications Quarterly Update – October 2012

United Nations Children’s Fund (UNICEF) UNICEF (2012)

With a focus on Pakistan and Nigeria’s most vulnerable communities, this report provides insight about the role that community push-back is playing in the transmission of the polio virus and how the Global Polio Eradication Initiative (GPEI) can mitigate these social risks to reach every missed ch... more

Download (299)

View PDF (247)

Air Pollution - Our overview of indoor and outdoor air pollution

Ritchie, H.; Roser, M. Global Change Data Lab (2024) CC2

The Our World in Data webpage on air pollution provides an extensive overview of the global impact of air pollution on health and the environment. It presents data on sources of pollution, such as industry, vehicles, and domestic energy use, and highlights the associated health risks, including resp... more

Download (526)

View PDF (666)

Infection Prevention and Control (IPC) Standard Operating Procedure (SOP) for Training/Meetings in the context of COVID-19
recommended

African Union; Africa CDC Centres for Disease Control and Prevention (2022) CC

1.0 PURPOSE To define the procedure for the conduct of in-person meetings in both healthcare and community settings in response to COVID-19 and with respect to Public Health and Social Measures (PHSMs) to reduce the risk of disease transmission. A general risk assessment must be conducted to inform... more

Download (376)

View PDF (552)

What people living with HIV need to know about HIV and COVID-19

UNAIDS (2020) CC

COVID-19 is a serious disease and all people living with HIV should take all recommended preventive measures to minimize exposure to, and prevent infection by, the virus that causes COVID-19. As in the general population, older people living with HIV or people living with HIV with heart or lung prob... more

External Link

Geographical, landscape and host associations of Trypanosoma cruzi DTUs and lineages

Izeta-Alberdi, A.; Ibarra-Cerdena, C.; Moo-llanes, D.; Ramsey,J. BMC Part of Springer Nature (2016) CC

Trypanosoma cruzi is the etiological agent of Chagas disease (CD), considered one of the most important parasitic infections in Latin America. Between 25 and 90 million humans are at infection risk via at least one of multiple infection mechanisms. Under natural conditions, the principal transmissio... more

External Link

Policy Snapshot: Cholesterol Control and Management in Brazil

World Heart Federation (2015) CC

Worldwide, there are about 17 million deaths due to cardiovascular disease (CVD) each year and at least two or three times as many non-fatal events. Raised cholesterol greatly increases the risks of stroke and heart disease, causing a large health burden across the world. The World Health Organizat... more

Download (271)

View PDF (453)

Why is adolescence a critical time for preventing drug addiction?

National Institute on Drug Abuse (NIDA) National Institutes of Health (NIH) (2020) CC

The webpage by the National Institute on Drug Abuse (NIDA) discusses strategies for preventing drug misuse and addiction. It highlights the importance of early intervention, education, and support systems to reduce risk factors and strengthen protective factors. The content emphasizes the role of fa... more

Download (353)

View PDF (272)

Epidemiology and Challenges of Managing COPD in sub-Saharan Africa

Magitta, N.F.; Sciences, A. Acta Scientific Medical Sciences (2018) CC2

There is paucity of data on the burden and specific drivers operative in the pathogenesis of chronic obstructive pulmonary disease (COPD) in the African setting and populations. Lack of awareness and inadequate knowledge on the aetio-pathogenesis of the disease together with inadequate capacity for ... more

Download (265)

View PDF (519)

The Global Burden of Disease Study at 30 years

Murray, C.J.L. nature medicine (2022) CC

The Global Burden of Disease Study (GBD) began 30 years ago with the goal of providing timely, valid and relevant assessments of critical health outcomes. Over this period, the GBD has become progressively more granular. The latest iteration provides assessments of thousands of outcomes for diseases... more

Download (595)

View PDF (788)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (523)

View PDF (667)

Social determinants of mental health

Fundação Calouste Gulbenkian World Health Organization WHO (2014) C_WHO

Good mental health is integral to human health and well being. A person’s mental health and many common mental disorders are shaped by various social, economic, and physical environments operating at different stages of life. Risk factors for many common mental disorders are heavily associated wit... more

Download (268)

View PDF (381)

Green Nutrition

Camp, O.; Remans, R.; Colston, J. Global Alliance for Improved Nutrition gain (GAIN) (2023) CC

The document emphasizes integrating environmental considerations into nutrition programs. It introduces a screening tool piloted across ten projects to identify environmental risks and opportunities, fostering sustainable practices in food systems. The tool promotes collaboration, co-learning, and a... more

Download (234)

View PDF (467)

Living Better with COPD Fact Sheet

National Heart, Lung, and Blood Institute (NHLBI) National Institutes of Health (NIH) (2022) CC2

The document provides information on managing chronic obstructive pulmonary disease (COPD). It emphasizes the importance of recognizing early symptoms such as persistent coughing, shortness of breath, and wheezing. The guide offers practical advice, including quitting smoking, avoiding lung irritant... more

Infection Prevention and Control (IPC) Standard Operating Procedure (SOP) for Training/Meetings in the context of COVID-19 recommended

Infection Prevention and Control (IPC) Standard Operating Procedure (SOP) for Training/Meetings in the context of COVID-19
recommended